Top Clinical Trials Stories


Comment & Analysis »

GBI Research

Do new diabetes discoveries deliver more benefits than risks?

The prevalence of diabetes is rising rapidly, and type 2 diabetes mellitus (T2DM), the most common form, affects over 160 million people in...

Do new diabetes discoveries deliver more benefits than risks?
GlobalData Healthcare

Carefully stepping away from RCTS: clinical trial design in a new medical era

Carefully stepping away from RCTS: clinical trial design in a new medical era
GlobalData Healthcare

Could Novartis’ longer-acting anti-VEGF Drug, RTH258, offset Lucentis’ loss to Eylea?

Could Novartis’ longer-acting anti-VEGF Drug, RTH258, offset Lucentis’ loss to Eylea?
GlobalData Healthcare

Insulin-related therapy: despite advances, unmet needs remain

Insulin-related therapy: despite advances, unmet needs remain
GlobalData Healthcare

EULAR 2017: Chondroitin Sulphate surprises with good results in knee osteoarthritis

EULAR 2017: Chondroitin Sulphate surprises with good results in knee osteoarthritis

Company Releases »

Pharmaceutical Consultant and FDA Regulatory Strategist

Pharmaceutical Development Group
Pharmaceutical Consultant and FDA Regulatory Strategist

Critical Containment Products for the Pharmaceutical Industry

PBSC
Critical Containment Products for the Pharmaceutical Industry

Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Kemwell Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Pharmaceutical Consulting and Generic Drug Professionals

Pharmaceutical Development Group
Pharmaceutical Consulting and Generic Drug Professionals

Paediatric Clinical Trials 2016

SMI Paediatric Clinical Trials 2016

Clinical Trials Insights »

Companies »